Glucose-Lowering Agents Nothing Short of Beneficial for Advanced CKD Patients

Galindo explained how the use of glucose-lowering agents in patients with diabetes and low eGFR improved patient care.

Pharmacy Times spoke to Rodolfo Galindo, MD, associate professor at the Emory School of Medicine, about his session at the ASN 2021 conference titled "Use of Glucose-Lowering Agents and Glycemic Monitoring in Advanced CKD.”

Galindo explained how the use of glucose-lowering agents in patients with diabetes and low eGFR improved patient care.